DE60021065D1 - Virus behandlung - Google Patents

Virus behandlung

Info

Publication number
DE60021065D1
DE60021065D1 DE60021065T DE60021065T DE60021065D1 DE 60021065 D1 DE60021065 D1 DE 60021065D1 DE 60021065 T DE60021065 T DE 60021065T DE 60021065 T DE60021065 T DE 60021065T DE 60021065 D1 DE60021065 D1 DE 60021065D1
Authority
DE
Germany
Prior art keywords
virus treatment
virus
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60021065T
Other languages
English (en)
Other versions
DE60021065T2 (de
Inventor
Berger Camden
Herman Gardner
Thomas Stanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAF Technologies and Research LLC
Original Assignee
UAF Technologies and Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAF Technologies and Research LLC filed Critical UAF Technologies and Research LLC
Application granted granted Critical
Publication of DE60021065D1 publication Critical patent/DE60021065D1/de
Publication of DE60021065T2 publication Critical patent/DE60021065T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE60021065T 1999-03-31 2000-03-29 Virus behandlung Expired - Fee Related DE60021065T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28189299A 1999-03-31 1999-03-31
US281892 1999-03-31
PCT/US2000/008419 WO2000057870A2 (en) 1999-03-31 2000-03-29 Viral treatment

Publications (2)

Publication Number Publication Date
DE60021065D1 true DE60021065D1 (de) 2005-08-04
DE60021065T2 DE60021065T2 (de) 2006-06-01

Family

ID=23079205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021065T Expired - Fee Related DE60021065T2 (de) 1999-03-31 2000-03-29 Virus behandlung

Country Status (11)

Country Link
US (2) US6194430B1 (de)
EP (1) EP1165077B1 (de)
JP (1) JP2002540151A (de)
AR (1) AR018706A1 (de)
AT (1) ATE298569T1 (de)
AU (1) AU763431B2 (de)
CA (1) CA2365495C (de)
CO (1) CO5160292A1 (de)
DE (1) DE60021065T2 (de)
NZ (1) NZ514558A (de)
WO (1) WO2000057870A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969367B2 (en) * 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US6613507B1 (en) 2000-03-21 2003-09-02 Yu-an Chang Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
AU2001249591A1 (en) 2000-03-30 2001-10-15 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
WO2001097749A2 (en) * 2000-06-23 2001-12-27 Kotze, Gavin, Salomon The use of synthetic, non-hormonal 21-aminosteroids and thereof
AU2002239395A1 (en) * 2000-11-01 2002-06-03 The Procter And Gamble Company Hiv treatment with benzimidazoles
AU2003220585A1 (en) * 2002-03-26 2003-10-13 Arizona Board of Regents on behalf of the University of Arizone Solubilization of weak bases
US7572448B2 (en) * 2002-07-15 2009-08-11 Board Of Regents, The University Of Texas System Combined cancer treatment methods using selected antibodies to aminophospholipids
NZ537690A (en) * 2002-07-15 2009-07-31 Univ Texas Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
US7615223B2 (en) * 2002-07-15 2009-11-10 Board Of Regents, The University Of Texas System Selected immunoconjugates for binding to aminophospholipids
US7625563B2 (en) * 2002-07-15 2009-12-01 Board Of Regents, The University Of Texas System Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
US7714109B2 (en) * 2002-07-15 2010-05-11 Board Of Regents, The University Of Texas System Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
US7622118B2 (en) * 2002-07-15 2009-11-24 Board Of Regents, The University Of Texas System Cancer treatment methods using selected antibodies to aminophospholipids
US7678386B2 (en) * 2002-07-15 2010-03-16 Board Of Regents The University Of Texas Liposomes coated with selected antibodies that bind to aminophospholipids
US20070053883A1 (en) * 2003-03-25 2007-03-08 The Johns Hopkins University Neuronal cell lineages and methods of production thereof
US20080027575A1 (en) * 2006-04-21 2008-01-31 Jones Stevan D Modeling systems for health and beauty consumer goods
CN110294751B (zh) * 2018-03-21 2020-11-20 湖南化工研究院有限公司 具生物活性的咪唑[4,5-b]并吡啶类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3590045A (en) 1969-09-25 1971-06-29 Smith Kline French Lab Certain substituted imidazo (4,5-b)pyridines
IL37752A (en) 1970-09-21 1974-10-22 Rhone Poulenc Sa Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same
AT379395B (de) * 1983-11-14 1985-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung von neuen 2(2-thienyl)-imidazo (4,5-b) pyridin-derivaten und deren pharmazeutisch vertraeglichen saeureadditionssalzen
DE3722992A1 (de) * 1987-07-11 1989-01-19 Thomae Gmbh Dr K Neue imidazo-pyridine und purine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AR018706A1 (es) 2001-11-28
AU4048900A (en) 2000-10-16
US6194430B1 (en) 2001-02-27
US20030232851A1 (en) 2003-12-18
WO2000057870A2 (en) 2000-10-05
NZ514558A (en) 2004-02-27
CA2365495A1 (en) 2000-10-05
AU763431B2 (en) 2003-07-24
WO2000057870A3 (en) 2001-03-08
DE60021065T2 (de) 2006-06-01
CA2365495C (en) 2007-01-02
EP1165077B1 (de) 2005-06-29
ATE298569T1 (de) 2005-07-15
JP2002540151A (ja) 2002-11-26
CO5160292A1 (es) 2002-05-30
EP1165077A2 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
DE60001421D1 (de) Behandlung von abgas
FI20000863A (fi) Uusi hoitomenetelmä
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ID29550A (id) Quinolinakarboksamida sebagai agen-agen antivirus
DE69915087D1 (de) Behandlung von textilien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60012138D1 (de) Gerät zur behandlung von fibrillation
NO20032122L (no) Forbedret behandling
ATE298569T1 (de) Virus behandlung
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE269391T1 (de) Wäschebehandlung
NO20005179D0 (no) Medikament behandling
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
DE60032884D1 (de) Blutbehandlungssystem
NO20013337D0 (no) Ny behandling
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE60103685D1 (de) Behandlung von Poriomania
NO20013596D0 (no) Slambehandling
DE60023003D1 (de) Haarbehandlungsmittel
DE60037935D1 (de) Kontinuierliches behandlungssystem
DE50005409D1 (de) Hör-behandlungsgerät
DE60011060D1 (de) Virus behandlung
DE60022086D1 (de) Wasserbehandlung
ATE290060T1 (de) Wäschebehandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee